What makes you think it's already a buyout target? seem like this drug has not reached Phase 1 yet, most of their drugs not in Phase 2, something you know?
haha this be crazy if it goes parabolic!
its not even hitting 5 yet, I thought it would gap up with the amount of shorts with tiny float
This is normal, imo it's actually a good thing, at least they have funds to continue R&D, still a low float, could have been worst!
Just buyers at $4ish last few days waking up now to take profits, and probably new shorts too, huge risk for shorts on such low float and positive news!
What price did you buy it at?